Extended-release naltrexone overlooked in opioid use disorders guideline

被引：1
|
作者：
Rieb, Launette M. [1 ]
机构：
[1] Univ British Columbia, Fac Med, Dept Family Practice, Vancouver, BC, Canada
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2018年 / 190卷 / 28期
关键词：
RANDOMIZED CONTROLLED-TRIAL; BUPRENORPHINE-NALOXONE; MEDICATIONS; DEPENDENCE;
D O I：
10.1503/cmaj.69411
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E862 / E862
页数：1
相关论文
共 50 条
  • [1] Extended-release naltrexone for youth with opioid use disorder
    Mitchell, Shannon Gwin
    Monico, Laura B.
    Gryczynski, Jan
    Fishman, Marc J.
    O'Grady, Kevin E.
    Schwartz, Robert P.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 130
  • [2] Injectable Extended-Release Naltrexone Effective for Opioid Use Disorder
    Slawson, David C.
    AMERICAN FAMILY PHYSICIAN, 2018, 97 (12) : 819 - 819
  • [3] A Comparison of Neuropsychological Functioning between Patients With Opioid Use Disorders on Extended-Release Naltrexone and Buprenorphine
    Castillo, Felipe
    Campbell, Aimee
    Choo, Tse-Hwei
    Pavlicova, Martina
    Rotrosen, John
    Selzer, Jeffrey A.
    Nunes, Edward, V
    DRUG AND ALCOHOL DEPENDENCE, 2025, 267
  • [4] Patient preferences and extended-release naltrexone: A new opportunity to treat opioid use disorders in Ukraine
    Marcus, Ruthanne
    Makarenko, Iuliia
    Mazhnaya, Alyona
    Zelenev, Alexei
    Polonsky, Maxim
    Madden, Lynn
    Filippovych, Sergii
    Dvoriak, Sergii
    Springer, Sandra A.
    Altice, Frederick L.
    DRUG AND ALCOHOL DEPENDENCE, 2017, 179 : 213 - 219
  • [5] Injectable extended-release naltrexone for opioid dependence
    Throckmorton, Douglas C.
    Temple, Robert
    Rappaport, Bob A.
    Roca, Rigoberto
    Winchell, Celia J.
    LANCET, 2011, 378 (9792): : 665 - 666
  • [6] Extended-release injectable naltrexone for opioid use disorder: a systematic review
    Jarvis, Brantley P.
    Holtyn, August F.
    Subramaniam, Shrinidhi
    Tompkins, D. Andrew
    Oga, Emmanuel A.
    Bigelow, George E.
    Silverman, Kenneth
    ADDICTION, 2018, 113 (07) : 1188 - 1209
  • [7] Injectable extended-release naltrexone for opioid dependence Reply
    Wolfe, Daniel
    Carrieri, M. P.
    Dasgupta, Nabarun
    Bruce, Douglas
    Wodak, Alex
    LANCET, 2011, 378 (9792): : 666 - 666
  • [8] Pharmacotherapy of opioid dependence with the extended-release injectable naltrexone
    Wang, A. L.
    Elman, I.
    Lowen, S.
    Blady, S. J.
    Lynch, K. G.
    O'Brian, C. P.
    Langleben, D. D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S696 - S696
  • [9] Extended-release naltrexone for opioid use disorder started during or following incarceration
    Lincoln, Thomas
    Johnson, Benjamin D.
    McCarthy, Patrick
    Alexander, Ellen
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2018, 85 : 97 - 100
  • [10] Outpatient Transition to Extended-release Naltrexone in Patients With Opioid-use Disorder
    Sullivan, Maria
    Mannelli, Paolo
    Yu, Miao
    Nangia, Narinder
    Graham, Christine
    Webster, Irena
    Tompkins, D. Andrew
    Kosten, Thomas
    Akerman, Sarah
    Silverman, Bernard
    AMERICAN JOURNAL ON ADDICTIONS, 2018, 27 (04): : 323 - 323
12345